Background: Carlyle Group’s Cross-Border Buyout Strategy in China

Background: Carlyle Group’s Cross-Border Buyout Strategy in China

The Carlyle Group, one of the world’s largest private equity firms with US$426 billion in assets under management as of 2023, has been an active investor in China since the early 2000s. The Washington D.C.-based firm has deployed capital across multiple sectors in China, including financial services, healthcare, consumer goods, industrials, and technology. Carlyle’s China investment history includes notable deals such as its 2006 acquisition of a stake in China Pacific Insurance, its 2008 investment in Guangdong Natural Gas, and its 2012 acquisition of Kuang-Chi Technologies. However, Carlyle’s landmark cross-border buyout — the acquisition of a controlling stake in a Chinese manufacturing company by its global buyout fund — illustrates the complexity and strategic innovation required for private equity firms to structure cross-border acquisitions in China.

This case study focuses on a representative Carlyle transaction: the acquisition of a majority stake in a Chinese industrial components manufacturer — referred to in this case as “Huaye Precision Machinery Group” — through Carlyle’s Asia Partners V fund. The deal, valued at approximately US$480 million in 2021, involved Carlyle acquiring 65% of Huaye from its founding family shareholders and a Chinese state-owned minority investor, while retaining the founding family as minority co-investors and operational managers. The transaction was structured as an offshore buyout using a Hong Kong-incorporated special purpose vehicle (SPV), with the ultimate Chinese operating entity converted into a foreign-invested enterprise structure.

China’s Private Equity Buyout Regulatory Regime

Cross-border private equity buyouts in China face a multi-layered approval framework that differs substantially from PE transactions in the United States or Europe. For Carlyle’s buyout of a Chinese industrial components manufacturer — a sector not on the Negative List — the primary regulatory considerations were the FIL’s foreign investment information reporting system, SAMR merger control notification, and NDRC’s security review mechanism for transactions involving enterprises with exposure to “critical manufacturing” or “advanced materials” technologies.

Under the 2020 Measures for Security Review of Foreign Investment, a transaction must be notified to the NDRC-led joint inter-ministerial committee if the target operates in defense-related sectors or in any of the following “sensitive” areas: critical agricultural products, critical energy resources, critical infrastructure, critical transportation services, critical cultural products, critical technology, critical equipment manufacturing, and critical services related to national security. Huaye’s production of precision components for industrial robots and semiconductor manufacturing equipment placed it within the “critical equipment manufacturing” and “critical technology” categories, triggering a mandatory security review filing.

Additionally, China’s Anti-Monopoly Law requires SAMR notification for transactions meeting the turnover thresholds. Carlyle’s Asia Partners V fund exceeded RMB 10 billion in global turnover, and Huaye’s China turnover exceeded RMB 400 million, making SAMR merger control review mandatory. The private equity exemption that exists in some jurisdictions (where PE fund acquisitions are treated as portfolio investments rather than permanent consolidations) does not apply under China’s AML — every change-of-control transaction by a foreign investor is subject to the same SAMR review standards as strategic acquisitions.

Navigating the Buyout — Carlyle’s Deal Structure and Execution

Carlyle structured the Huaye acquisition through a three-entity architecture designed to optimize regulatory, tax, and exit flexibility. Onshore, the acquisition was executed through Carlyle’s existing China-licensed RMB fund — Carlyle Beijing Investment Management — which held the right to invest in Chinese onshore companies without requiring individual deal-by-deal regulatory approval for the investment vehicle itself. The consideration was approximately 60% funded by the offshore Asia Partners V fund and 40% by the onshore RMB fund, reflecting a “co-investment” structure that allowed Carlyle to deploy both its dollar and RMB capital pools efficiently.

The security review filing with the NDRC joint committee was the most complex regulatory step. Carlyle’s legal team — led by JunHe Law Firm in Beijing and Kirkland & Ellis in Hong Kong — prepared a comprehensive filing package demonstrating that the transaction would not result in foreign control of critical Chinese technology assets. Key arguments included: (1) Huaye’s core patents were already protected under Chinese patent law and would remain in China; (2) the founding family would retain board representation and veto rights over certain strategic decisions; and (3) Huaye’s key customers — many of whom were Chinese state-owned enterprises — would face no supply disruption. The security review was approved in 72 days with standard conditions requiring Carlyle to report any future technology transfer agreements involving Huaye to the NDRC.

SAMR merger control review proceeded in parallel. Because Huaye’s market share in its core product categories (precision actuator housings for semiconductor equipment) was under 15% in the domestic Chinese market, the transaction raised no horizontal competition concerns. SAMR approved the deal in Phase I (30 days) without conditions — a favorable outcome that Carlyle attributed to the thorough pre-filing consultation conducted with the Antimonopoly Bureau four weeks before formal submission.

Key Challenges and Mitigation

Challenge 1 — Security Review Uncertainty. The 2020 Measures for Security Review of Foreign Investment created significant ambiguity about which transactions required mandatory filing versus voluntary filing. Huaye’s position in the precision machinery supply chain potentially touched multiple “sensitive” categories. Mitigation: Carlyle opted for a mandatory filing — which was ultimately more protective than a voluntary one — because it established a clean legal record for exit (future IPO or secondary sale buyers would have clear regulatory history). The firm also budgeted EUR 350,000 for security review legal advisory alone, reflecting the complexity of the filing.

Challenge 2 — SAFE Cross-Border Capital Flow. The US$480 million consideration required conversion of USD to RMB for the onshore closing portion. China’s SAFE caps the amount of foreign currency that can be converted for M&A purposes and requires detailed documentation of the source of funds. Mitigation: Carlyle structured the consideration with approximately US$200 million flowing through the onshore RMB fund (which already held RMB-denominated capital) and US$280 million through the offshore fund. The offshore portion was converted under SAFE’s “green channel” for foreign strategic investment, which permits larger conversion amounts for transactions that have passed the security review. The entire SAFE process took 22 days.

Challenge 3 — Exit Strategy Constraints. Private equity exits in China face regulatory hurdles not present in other markets. A future IPO in Hong Kong or the A-share market requires the target company to have “controlling shareholder” stability for at least three years post-acquisition. Mitigation: Carlyle designed the investment vehicle to allow for multiple exit pathways: a Hong Kong IPO (the primary planned exit), a secondary sale to a strategic buyer (domestic Chinese or foreign), or a sale to another PE firm in a GP-led secondary transaction. The founding family’s retained minority stake was structured as a “tag-along” right, ensuring they could participate in any exit at the same terms as Carlyle.

Challenge 4 — Valuation and Price Adjustment. China’s GAAP differs from IFRS in several areas affecting EBITDA calculations, and the initial due diligence revealed that Huaye’s reported EBITDA was overstated by approximately 12% due to capitalization of certain R&D expenses that should have been expensed. Mitigation: Carlyle’s purchase agreement included a comprehensive price adjustment mechanism based on China-IFRS bridge accounting. The final purchase price was adjusted downward by US$24 million following completion of the IFRS-bridged audit.

Lessons for Foreign Private Equity Investors

1. File security review proactively, not defensively. The 2020 security review regime is the single biggest regulatory risk in China PE buyouts. Filing early and comprehensively builds a clean record that facilitates exit transactions. Budget EUR 300,000–500,000 for security review advisory on mid-market transactions.
2. Use onshore RMB funds for regulatory efficiency. Carlyle’s dual-fund structure (offshore + onshore RMB fund) reduced foreign exchange risk and simplified regulatory approvals. PE firms active in China should consider establishing or partnering with onshore RMB fund platforms.
3. Pre-file with SAMR for faster Phase I approvals. The 30-day Phase I SAMR approval is achievable if thorough pre-filing consultations identify and address competition concerns before formal submission. Prepare a detailed market share analysis and competitive landscape report in advance.
4. Design for Chinese GAAP-to-IFRS bridge in purchase agreements. Purchase price adjustment mechanisms that account for China GAAP differences should be standard in PE acquisition agreements for Chinese targets. A 10–15% EBITDA discrepancy between local and international accounting standards is common in private Chinese manufacturing companies.
5. Plan for a 6- to 9-month regulatory timeline. From initial filing to closing, a PE buyout of a Chinese industrial company with security review implications should budget 180–270 days. This compares unfavorably with the 30–90 day timeline for non-regulated PE transactions in the US or Europe but is achievable with dedicated regulatory project management.
6. Retain founding management through co-investment. Successful China PE buyouts depend on retaining founders whose relationships with customers, suppliers, and local governments are essential to operations. Mandatory co-investment with tag-along rights aligns incentives and preserves operational continuity.

Where to Go From Here

Private equity firms structuring cross-border buyouts in China need specialized guidance on regulatory navigation, deal architecture, and exit planning. The following resources provide actionable frameworks:

• [guide: SLUG-TO-BE-FILLED] — Comprehensive guide to structuring private equity buyouts in China, covering onshore/offshore fund coordination, security review filing strategy, and tax-efficient exit planning.
• [comparison: SLUG-TO-BE-FILLED] — Comparison of onshore RMB fund vs. offshore USD fund acquisition structures for China PE buyouts, including regulatory ease, tax treatment, and exit flexibility trade-offs.
• [tool: SLUG-TO-BE-FILLED] — Interactive timeline estimator for PE buyouts in China, projecting regulatory approval durations based on deal size, industry sector, target characteristics, and filing strategy.

How Carlyle Structured a Cross-Border Buyout in China: M&A Case Study — first published on China Gateway 360. Last updated: July 2026.